Loading...
XNAS
ASPI
Market cap429mUSD
Jul 09, Last price  
5.15USD
1D
4.15%
1Q
14.84%
IPO
83.75%
Name

ASP Isotopes Inc

Chart & Performance

D1W1MN
XNAS:ASPI chart
P/E
P/S
17.93
EPS
Div Yield, %
Shrs. gr., 5y
19.30%
Rev. gr., 5y
1.06%
Revenues
24m
+475.51%
22,625,00000433,0264,144,00023,849,000
Net income
-175m
L+441.51%
-10,256,000-2,607,927-4,945,139-16,286,234-32,334,000-175,092,000
CFO
-38m
L+126.29%
-577,692-2,939,893-5,412,392-16,695,365-37,780,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
IPO date
Nov 10, 2022
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT